整合和简化证据以优化心脏指导治疗
Harleen Singh1, Carrie Puckett2, Yennie Q Lucas3
1School of Pharmacy, The University of Texas at El Paso, 500 W. University Avenue, El Paso, TX 79968, USA.
Journal of clinical medicine
|August 28, 2025
概括
早期检测和优化心治疗对于减缓慢性病 (CKD) 的进展至关重要. 在治疗慢性病及其心血管并发症方面,
科学领域:
- 肝脏病学
- 心脏病学
- 内部医学
背景情况:
- 慢性病 (CKD) 是一个日益严重的全球健康问题,
- 慢性病显著增加了心血管疾病 (CVD) 并发症的风险,而这些并发症是患病者死亡的主要原因.
- 心脏病综合征突显了心脏和脏健康之间的复杂联系,
研究的目的:
- 审查慢性病早期检测策略的证据.
- 通过优化心治疗来减缓慢性病的现实机会.
- 强调管理高血压和糖尿病等共同风险因素的重要性.
主要方法:
- 关于慢性病检测和管理的现有证据的文献综述.
- 对心脏和脏疾病的指导医学治疗分析.
- 对慢性病新兴药物治疗方法的评估.
主要成果:
- 与传统疗法相比,新兴药物,包括SGLT2抑制剂和MRA,在减缓CKD进展方面表现出更高的疗效.
- 优化心指导医学治疗可以显著影响患者的结果.
- 早期发现和及时干预对于改善慢性病患者的预后至关重要.
结论:
- 综合治疗心脏病是降低死亡率的关键.
- 新的治疗药物为慢性病的进展提供了新的希望.
- 应对未诊断的CKD和改善对护理的准入,特别是在资源较少的环境中,仍然是优先事项.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Chronic Kidney Disease III: Interprofessional Care
77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Chronic Kidney Disease IV: Nursing Management
54
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
54
Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483
Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44


